NeuroPsyBiT-BD Omics: Genomic & Epigenomic Biobank of Bipolar Disorder

Not yet recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

October 1, 2027

Study Completion Date

October 1, 2027

Conditions
Bipolar Disorder
Interventions
OTHER

Biobanking and Phenotypic Data Collection

This intervention involves the systematic collection of blood samples (EDTA tubes for DNA extraction) and detailed phenotypic/clinical data using the NeuroCybe Data Collector software. All biospecimens are processed and stored at the RTSGD-NeuroPsyBiT Biobank under ISO-compliant procedures. Data are entered into a secure on-premises server infrastructure (GDPR/KVKK compliant) for long-term use in genomic and epigenomic studies. No therapeutic intervention is applied; all activities are non-invasive and focused on sample and data acquisition.

Trial Locations (1)

42130

Selçuk University Faculty of Medicine, Department of Psychiatry / NeuroPsyBiT-RTSGD Consortium, Konya

All Listed Sponsors
collaborator

Research and Treatment Society of Genetic Disorders

OTHER

lead

Selçuk State Hospital

OTHER

NCT07173842 - NeuroPsyBiT-BD Omics: Genomic & Epigenomic Biobank of Bipolar Disorder | Biotech Hunter | Biotech Hunter